JPS5673025A - Metabolism exciting agent - Google Patents

Metabolism exciting agent

Info

Publication number
JPS5673025A
JPS5673025A JP15093879A JP15093879A JPS5673025A JP S5673025 A JPS5673025 A JP S5673025A JP 15093879 A JP15093879 A JP 15093879A JP 15093879 A JP15093879 A JP 15093879A JP S5673025 A JPS5673025 A JP S5673025A
Authority
JP
Japan
Prior art keywords
metabolism
soybean saponin
glucopyranosyl
prevention
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15093879A
Other languages
Japanese (ja)
Other versions
JPS6016925B2 (en
Inventor
Shigeru Yuchi
Yoshihiro Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OSAKA YAKUHIN KENKYUSHO KK
Osaka Chemical Laboratory Co Ltd
Original Assignee
OSAKA YAKUHIN KENKYUSHO KK
Osaka Chemical Laboratory Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OSAKA YAKUHIN KENKYUSHO KK, Osaka Chemical Laboratory Co Ltd filed Critical OSAKA YAKUHIN KENKYUSHO KK
Priority to JP54150938A priority Critical patent/JPS6016925B2/en
Priority to DE3040246A priority patent/DE3040246C2/en
Publication of JPS5673025A publication Critical patent/JPS5673025A/en
Priority to US06/487,096 priority patent/US4524067A/en
Publication of JPS6016925B2 publication Critical patent/JPS6016925B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)

Abstract

PURPOSE: To provide an agent for exciting metabolism, suppressing the formation of lipid peroxide, useful for the prevention and remedy of arteriosclerosis, myocardosis, cerebral thrombosis, etc. and prevention of senility, and composed of a soybean saponin component and a vehicle.
CONSTITUTION: An agent composed of a soybean saponin component [e.g. a saponin of formula such as 3-0-[β-D-glucopyranosyl(1→2)-β-D-galactopyranosyl ( 1→2 )-β-D-glucuronopyranoxyl ]-21-0-[ β-D-glucopyranosyl( 1→3 )-α-L-arabinopyranosyl]-soyasapogenol A] and a pharmaceutically acceptable vehicle. The administration of the soybean saponin suppresses the production of lipid peroxide in the heart and liver, etc., and its activity is comparable to that of vitamin E. Furthermore, the soybean saponin is safe, available at a low cost, and water-soluble.
COPYRIGHT: (C)1981,JPO&Japio
JP54150938A 1979-10-29 1979-11-20 Metabolic agents Expired JPS6016925B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP54150938A JPS6016925B2 (en) 1979-11-20 1979-11-20 Metabolic agents
DE3040246A DE3040246C2 (en) 1979-10-29 1980-10-24 Soy Saponins A ↓ 1 ↓ and A? 2? and their use
US06/487,096 US4524067A (en) 1979-10-29 1983-04-21 Soybean saponins, and a method of isolating the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54150938A JPS6016925B2 (en) 1979-11-20 1979-11-20 Metabolic agents

Publications (2)

Publication Number Publication Date
JPS5673025A true JPS5673025A (en) 1981-06-17
JPS6016925B2 JPS6016925B2 (en) 1985-04-30

Family

ID=15507686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54150938A Expired JPS6016925B2 (en) 1979-10-29 1979-11-20 Metabolic agents

Country Status (1)

Country Link
JP (1) JPS6016925B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5955895A (en) * 1982-09-27 1984-03-31 Osaka Chem Lab Soyasaponin
JPS59106410A (en) * 1982-12-09 1984-06-20 Osaka Chem Lab Cosmetic composition containing saponin of soybean
JPS60224629A (en) * 1984-04-23 1985-11-09 Kao Corp Inhibitor composition for in vivo lipoperoxide formation
JPS617286A (en) * 1984-06-22 1986-01-13 Kishimoto Sangyo Kk Production of isolated saponin
JPS617285A (en) * 1984-06-22 1986-01-13 Kishimoto Sangyo Kk Extraction of purified saponin
JPS6124522A (en) * 1984-07-13 1986-02-03 Kao Corp Inhibitor composition for formation of skin peroxylipid
US5141746A (en) * 1989-11-10 1992-08-25 Nestec S.A. Process for obtaining genistin malonate and daidzin malonate

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5955895A (en) * 1982-09-27 1984-03-31 Osaka Chem Lab Soyasaponin
JPS59106410A (en) * 1982-12-09 1984-06-20 Osaka Chem Lab Cosmetic composition containing saponin of soybean
JPS60224629A (en) * 1984-04-23 1985-11-09 Kao Corp Inhibitor composition for in vivo lipoperoxide formation
JPH053453B2 (en) * 1984-04-23 1993-01-14 Kao Corp
JPS617286A (en) * 1984-06-22 1986-01-13 Kishimoto Sangyo Kk Production of isolated saponin
JPS617285A (en) * 1984-06-22 1986-01-13 Kishimoto Sangyo Kk Extraction of purified saponin
JPS6124522A (en) * 1984-07-13 1986-02-03 Kao Corp Inhibitor composition for formation of skin peroxylipid
JPH053454B2 (en) * 1984-07-13 1993-01-14 Kao Corp
US5141746A (en) * 1989-11-10 1992-08-25 Nestec S.A. Process for obtaining genistin malonate and daidzin malonate

Also Published As

Publication number Publication date
JPS6016925B2 (en) 1985-04-30

Similar Documents

Publication Publication Date Title
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
JPS61280424A (en) Blood vessel protector
KR970061909A (en) Ginseng saponin intestinal bacterial metabolites and anti-cancer agents containing the same as active ingredients
JPS5673025A (en) Metabolism exciting agent
CA2030962A1 (en) Improvements relating to the administration of pharmaceutical agents
JPS5228947A (en) Oral remedy for hyperlipemia
JPS5716818A (en) Steroid fatty emulsion
Aftergood et al. Effect of oral contraceptives on plasma lipoproteins, cholesterol and alpha-tocopherol levels in young women
JPS5718617A (en) Antilipemic agent
JPS57188520A (en) Antihyperkalemia
WO1991015466A3 (en) Aminopolycarboxylic acid chelating agents
JPS5782319A (en) Antitumor agent
JPS5793913A (en) Enhancing agent for spermous vital power
JPS57163315A (en) Preventing agent and remedy for thrombosis
JPS51144733A (en) A remedy for hepatic failure
JPS55122724A (en) Antidiabetic agent
EP0333678A3 (en) Use of glycerol ethers in the treatment of allergic diseases
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS57116017A (en) Antithrombogenetic or anticoagulative agent
JPS5484034A (en) Anti-tumor agent
JPS51144732A (en) A remedy for hepatic failure
JPS56125305A (en) Creamy or milky lotion cosmetic
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
EP0242554A3 (en) Use of coenzyme a as an antimutagenic agent